Background The coronavirus disease 2019 (COVID-19) pandemic has been a global health
emergency since December 2019, leading to millions of deaths worldwide and placing …

Objectives This study aimed to estimate the cost-effectiveness of remdesivir, the first novel
therapeutic to receive Emergency Use Authorization for the treatment of hospitalized …

Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …

Background: The role of remdesivir in the treatment of hospitalized patients with COVID-19
remains ill-defined. We conducted a cost-effectiveness analysis alongside the Canadian …

Aims The present study aimed to evaluate the cost‐effectiveness of the 5‐day remdesivir
regimen compared with standard of care among severe COVID‐19 patients in China, the …

Introduction In addition to significant morbidity and mortality, the coronavirus disease
(COVID-19) has strained health care systems globally. This study investigated the cost …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of SARS-CoV-2. Methods This was a retrospective comparative …

Abstract Background Coronavirus disease 2019 (COVID-19), caused by the novel
coronavirus SARS-CoV-2, has led to significant global mortality and morbidity. Until now, no …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Abstract Background Sars-Cov-2 is a novel corona virus associated with significant
morbidity and mortality. Remdesivir and Dexamethasone are two treatments that have …